Follow us on LinkedIn
NTC España website
NTC
Novelty, Technology, Care
NTC launches Imperial, the new eye drops product line on THE PATIENT’S SIDE
NTC, an international pharmaceutical company headquartered in Milan, Italy, announced today to have embraced a strategic partnership with Silgan Dispensing Systems
Read More
Cataract surgery: the fixed-dose combination of an antibiotic with an anti-inflammatory drug in eye drops is currently available in 50 countries worldwide
The combination has been registered in nearly 60 countries for the prevention and treatment of inflammation and the prevention of infection associated with cataract surgery in adults. It is currently marketed in 50 countries worldwide.
Read MoreNTC is an international R&D-driven pharmaceutical company headquartered in Milan, Italy, with distributors and partners in over 100 countries in the world, engaged in research, development, registration and commercialization of drugs, medical devices, and food supplements in ophthalmology, but also in other therapeutic areas like gastro-metabolism, gynecology, and pediatrics.
NTC is the first Italian pharmaceutical company to launch in ophthalmology an innovative therapeutic solution globally: a drug to appropriately manage the prevention of infection and to treat inflammation in patients after cataract surgery.
NTC offers to its partners, currently nearly 250 companies, innovative pharmaceutical products with high quality standards. In addition to our B2B model, NTC carries out direct commercial activities in Italy and Spain, with field forces entirely focused on Ophthalmology. NTC is controlled by private equity funds: Wise Equity SGR S.p.A., Unigestion GP S.à.r.l., and Racer S.r.l.
NOVELTY and TECHNOLOGY for CARE
Advanced scientific research and technology are the engine of NTC innovation in care practices.
NTC innovation translates into the discovery of new and specific therapeutic gestures that are simpler and more intuitive, sustainable, healthier and technically adequate.
Partnering
NTC is making a fresh model of partnership designed to provide solutions to increase the potential and the value of the relationship and to add mutual and competitive advantages for both us and our partners.Read more
Therapeutic Solutions
If research is the soul of NTC, improving the care experience constitutes the essence of its vocational offer. Prior to being realized in the product, research is embodied in the accompanying therapeutic gestures.
Other than constituting the backbone of NTC business, rigorous and diffused experimentations on patients, Scientific Advice, scientific publications and the transparent disclosure of results are a working methodology, which is the essential guiding spirit of the company.
NTC research aims at placing innovation within everyone's reach. NTC product portfolio is broad, mostly in Ophthalmology but diversified in Gynecology, Gastroenterology, and Pediatrics too.
News & Events
-
NTC launches Imperial, the new eye drops product line on THE PATIENT’S SIDE- Oct 7, 2024
NTC, an international pharmaceutical company headquartered in Milan, Italy, announced… -
Cataract surgery: the fixed-dose combination of an antibiotic with an anti-inflammatory drug in eye drops is currently available in 50 countries worldwide- Sep 24, 2024
The combination has been registered in nearly 60 countries for… -
-
PHARMACOVIGILANCE